Better patients’ treatment experiences are associated with better postoperative results in Dupuytren’s disease

Poelstra, Ralph; Selles, Ruud W.; Slijper, Harm P.; Feitz, Reinier; Hovius, Steven E.R.; Porsius, Jarry T.

doi:10.1177/1753193418780187

Cited by 16 publications

(20 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…More specifically, we consistently found positive associations between patient experiences on care delivery and improvement in patient-reported outcome measures following surgical treatments. 5,22,23 The strongest associations were found for positive experiences with the communication of the surgeon and providing treatment information, which is in line with other studies. 5,22,23…”

Section: Health Care Context and Treatment Outcomessupporting

confidence: 90%

“…Furthermore, the Dutch Patient Reported Experience Measure is used. 5 Next, we created "measurement tracks," consisting of a specific set of measurements administered at predetermined time points for each treatment or condition. We aimed to create as few measurement tracks as possible, based on similarity in the relevance of outcome domains and time points needed to capture the patients' health status.…”

Section: Measurementsmentioning

confidence: 99%

“…Plastic and Reconstructive Surgery • August 2020 challenges. These include lack of (1) consensus on which outcome measurements should be collected; (2) appropriate information technology infrastructure for data collection; (3) time and financial resources for data collection; (4) compliance of both patients and health care providers in data collection; (5) analysis and visualization tools; and (6) knowledge to improve clinical care by using the data.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Routine Health Outcome Measurement: Development, Design, and Implementation of the Hand and Wrist Cohort

Selles¹,

Wouters²,

Poelstra³

et al. 2020

Plastic &Amp; Reconstructive Surgery

Self Cite

View full text Add to dashboard Cite

outine measurement of the outcome of clinical care is increasingly considered important in health care. It is a key aspect of value-based health care, patient-centered care, and other quality-of-care initiatives. 1 For example, the Dutch government strives to have objective outcome data on 50 percent of all health care in 2022, 2 and in Sweden, outcome measurements have been part of a national registry for years. 3 The goals of routine outcome measurement are multiple, including improving communication and treatment guidance at the patient level, in addition to benchmarking of outcome at the level of individual clinicians or treatment centers. This benchmark information may help to establish priorities in resource allocation, and provide clinicians and managers with valuable feedback on performance. Furthermore, routine outcome measurement systems generate large data sets that can be used in scientific research. These "big data" can help provide knowledge on, for example, comparative effectiveness, predictive factors of outcome, and psychometric properties of measurement instruments. Although routine outcome measurement has been advocated for years, implementation in clinical practice is limited because of several

show abstract

Section: Health Care Context and Treatment Outcomessupporting

confidence: 90%

Section: Measurementsmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Routine Health Outcome Measurement: Development, Design, and Implementation of the Hand and Wrist Cohort

Selles¹,

Wouters²,

Poelstra³

et al. 2020

Plastic &Amp; Reconstructive Surgery

Self Cite

View full text Add to dashboard Cite

show abstract

“…The effectiveness of the treatment in our study, measured as the decrease in the degree of contracture of the fingers before and after treatment with CCH, was 26.67 for MCP and 23.39 for PIP, significant decreases that replicate the results obtained previously by other authors [11][12][13]. However, this effectiveness only indicates a correct administration of the medication and the consequent destruction of DD cord to a greater or lesser extent, the real effectiveness of the treatment being valued over time and measured in the form of relapse rates [13].…”

Section: Discussionsupporting

confidence: 91%

Usefulness of the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) Questionnaire in Dupuytren's Disease: A Prospective Cohort Study

Herrero¹,

Sanjuán-Cerveró²,

Alonso³

et al. 2019

Arch Med

View full text Add to dashboard Cite

Background: Dupuytren's Disease (DD) is a fibroproliferative disease which affects the hands and can produce progressive and irreversible flexion contractures. Collagenase Clostridium histolyticum (CCH) is a minimallyinvasive treatment option for it. Hand function and patient´s satisfaction were commonly measured by the Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. The Spanish QuickDASH is the only validated Spanish region-specific questionnaire can be employed for the clinical assessment of patients with pathologies of the hand, such as Dupuytren's Disease. The aim of the study was to determine the usefulness of the abbreviated Spanish version of the QuickDASH, as an effective tool for evaluation of Dupuytren's disease treatment outcomes and their correlation with objective outcomes measuring improvement in residual contracture following treatment. Methods: We conducted a prospective cohort study from April 2016 to June 2017 involving the selection of patients from three different hospitals. The measurement of the clinical results was made by calculating the difference between prior and post-treatment degrees of contraction (Thomine´s coefficient) and QuickDASH questionnaire was self-administered by patients pre-and post-treatment. Results: 46 patients (66.1 ± 1.1 years) completed the study. The mean correction for the metacarpophalangeal joint was-26.67 degrees (p<0.001) and-23.39 degrees for the proximal interphalangeal joint. The mean change in QuickDASH score was 8.88 (p<0.001) at a mean 34.6-day follow-up. The study showed a low correlation between the QuickDASH scores and the improvement in mobility, showing a weak relation between the scores (r<0.2). Conclusion: In our study, QuickDASH questionnaire scores for the treatment of Dupuytren´s disease did not correlate with clinical outcomes.

show abstract

“…Actualmente la valoración de la necesidad de tratamiento se basa en muchas ocasiones, en la decisión de necesidad o no de los pacientes, 19 dejando un tanto de lado la valoración clásica [20][21][22][23] aunque como todo con la ED hay inconsistencia en cuanto a resultados y consenso. 24 En el apartado de las recurrencias, la técnica preferida en todos los supuestos es la FSC con mucha diferencia.…”

Section: Discussionunclassified

Current Trends in the Treatment of Dupuytren Disease in Spain

Sanjuán-Cerveró

Herrero

Novoa-Parra

et al. 2020

Revista Iberoamericana de Cirugía de la Mano

View full text Add to dashboard Cite

Objective Assessment of the treatment trends of Spanish surgeons in clinical practice by making clinical assumptions in Dupuytren's disease (DD). Material and Method A survey was sent to the members of the Spanish Society for Surgery of the Hand (Sociedad Española de Cirugía de la Mano, SECMA) posing primary and secondary clinical cases. A relationship is established between the selected treatment, the characteristics of the participating surgeons, and the characteristics of the primary clinical cases. Treatment preferences in recurrences are assessed descriptively. Results In total, 127 surveys were answered. 62.2% of the participants had experience with the use of collagenase and were the basis of the analysis. In primary cases, surgeons with more practice time tended to choose collagenase as treatment for DD. Surgeons who reported higher frequency of collagenase use (67.4% vs. 25.7%) were up to 6 times more likely to indicate such treatment. The patient's age under 50 years was the variable with the greatest association strength for the choice of collagenase treatment (OR = 3.8; CI95% 1.9–7.6). In recurrences, among all clinical cases, the most common answer given by the surgeons was partial fasciectomy. Conclusions Partial fasciectomy continues to be the most widely used treatment for DD in Spain. In primary cases, collagenase is an alternative adopted by experienced surgeons, and in treatments for young patients. In recurrences, partial fasciectomy is the preferred technique.

show abstract

Better patients’ treatment experiences are associated with better postoperative results in Dupuytren’s disease

Cited by 16 publications

References 20 publications

Routine Health Outcome Measurement: Development, Design, and Implementation of the Hand and Wrist Cohort

Routine Health Outcome Measurement: Development, Design, and Implementation of the Hand and Wrist Cohort

Usefulness of the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) Questionnaire in Dupuytren's Disease: A Prospective Cohort Study

Current Trends in the Treatment of Dupuytren Disease in Spain

Contact Info

Product

Resources

About